133 related articles for article (PubMed ID: 1257278)
1. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
Terhaag B; Förster W; Mest HJ; Schrör K
Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
[No Abstract] [Full Text] [Related]
2. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
Femmer K; Grünheid K
Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
[No Abstract] [Full Text] [Related]
3. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
Terhaag B; Förster W
Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
[No Abstract] [Full Text] [Related]
4. [Structure-activity relationship in various 4-substituted ajmaline derivatives].
Femmer K; Gabsch G; Braun K
Pharmazie; 1976; 31(1):36-9. PubMed ID: 1257277
[No Abstract] [Full Text] [Related]
5. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
Diederich KW; Boyksen D
Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
[No Abstract] [Full Text] [Related]
6. [Chronic toxicity of 4-[3'-diethylamino-2'hydroxypropyl]-ajmaline hydrogen tartrate (Tachmalcor) in the rat].
Grimm I; Sziegoleit W; Riedel H; Förster W
Pharmazie; 1976; 31(1):44-7. PubMed ID: 3809
[No Abstract] [Full Text] [Related]
7. Cardiovascular effects and blood concentrations of ajmaline and its 17-monochloroacetate ester in cats.
Spilker B; Shargel L; Koss RF; Minatoya H
Arch Int Pharmacodyn Ther; 1975 Jul; 216(1):63-78. PubMed ID: 1164107
[TBL] [Abstract][Full Text] [Related]
8. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
von Philipsborn G
Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
[No Abstract] [Full Text] [Related]
9. [The effect of N-(n-propyl)-ajmalinium-hydrogentartrate on canine hemodynamics].
Mertens HM; Schelbert HR; Kreuzer H; Spiller P; Schmiel FK
Arzneimittelforschung; 1973 May; 23(5):642-5. PubMed ID: 4740203
[No Abstract] [Full Text] [Related]
10. ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.
Lindner E; Schölkens B
Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):19-23. PubMed ID: 4367710
[No Abstract] [Full Text] [Related]
11. Effects of ajmaline and N-propylajmaline on maximum follow frequency and contractility of the dog heart: short communication.
Raschack M
Arzneimittelforschung; 1975 Jun; 25(6):896-8. PubMed ID: 1174325
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on the contractile and hemodynamic effects of antiarrhythmic agents (lidocaine, diphenylhydantoin, ajmaline) (author's transl)].
Strauer BE
MMW Munch Med Wochenschr; 1976 Mar; 118(12):365-70. PubMed ID: 817165
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol.
Castellucci A
Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206
[TBL] [Abstract][Full Text] [Related]
14. Effect of Ajmaloon on the baroreceptor-heart rate reflex in anaesthetized rabbits and monkeys.
Fahim M; Khan MS; Hameed HA
Indian J Physiol Pharmacol; 1995 Apr; 39(2):101-5. PubMed ID: 7649595
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic and cardiovascular properties of 17-monochloroacetylajmaline (17-MCAA).
Capra C; Cristoni A; Lietti A; Picci M; Santi-Soncin E
Farmaco Prat; 1980 Feb; 35(2):49-70. PubMed ID: 7449939
[No Abstract] [Full Text] [Related]
16. [Effect of propranolol and alcohol on hemodynamics and fatality in the rat].
Hepp A
Z Kardiol; 1985 May; 74(5):261-5. PubMed ID: 4013461
[TBL] [Abstract][Full Text] [Related]
17. [The influence of antiarrhythmic drugs on the exercise-ecg (author's transl)].
Raff U; Hepp A
Z Kardiol; 1977 Feb; 66(2):61-5. PubMed ID: 842073
[TBL] [Abstract][Full Text] [Related]
18. [Oral treatment of continuous ventricular extrasystole with detajmiumbitartrate (Tachmalcor)--clinical studies on effectiveness and dose-time-effect relations including intraindividual therapy comparisons with ajmaline (Tachmalin)].
Wruck C; Hofmann H; Sziegoleit W; Förster W
Z Gesamte Inn Med; 1982 Aug; 37(16):519-25. PubMed ID: 6183840
[TBL] [Abstract][Full Text] [Related]
19. [Clinical use of ajmaline].
Fomina IG
Klin Med (Mosk); 1973 Nov; 51(11):9-15. PubMed ID: 4132418
[No Abstract] [Full Text] [Related]
20. Cardiovascular effects of ajmaline.
Obayashi K; Nagasawa K; Mandel WJ; Vyden JK; Parmley WW
Am Heart J; 1976 Oct; 92(4):487-96. PubMed ID: 961588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
